Recent Finacing
Recent Raise
Harm Reduction Therapeutics is a nonprofit pharmaceutical developer creating a low-cost intranasal naloxone spray pursuing FDA OTC approval to expand community access for opioid overdose reversal.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Harm Reduction Therapeutics.
